Annual CFO
-$71.85 M
-$24.69 M-52.33%
December 31, 2022
Summary
- As of February 10, 2025, GRCL annual cash flow from operations is -$71.85 million, with the most recent change of -$24.69 million (-52.33%) on December 31, 2022.
- During the last 3 years, GRCL annual CFO has fallen by -$52.25 million (-266.58%).
Performance
GRCL Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFO
N/A
September 30, 2023
Summary
- GRCL quarterly cash flow from operations is not available.
Performance
GRCL Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
N/A
September 30, 2023
Summary
- GRCL TTM cash flow from operations is not available.
Performance
GRCL TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
GRCL Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -52.3% | - | - |
| 3 y3 years | -266.6% | - | - |
| 5 y5 years | -667.9% | - | - |
GRCL Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +52.3% | at low | ||||
| 5 y | 5-year | +266.6% | at low | ||||
| alltime | all time | +667.9% | at low |
Gracell Biotechnologies Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$40.21 M(+29.8%) | -$40.21 M(+29.8%) |
| Dec 2022 | -$71.85 M(+52.3%) | - | - |
| Jun 2022 | - | -$30.97 M(+55.6%) | -$30.97 M(-21.2%) |
| Dec 2021 | -$47.17 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$19.90 M(+2.7%) | -$39.29 M(+102.7%) |
| Dec 2020 | -$28.71 M(+46.5%) | - | - |
| Sep 2020 | - | -$19.38 M | -$19.38 M |
| Dec 2019 | -$19.60 M(+109.5%) | - | - |
| Dec 2018 | -$9.36 M | - | - |
FAQ
- What is Gracell Biotechnologies annual cash flow from operations?
- What is the all time high annual CFO for Gracell Biotechnologies?
- What is Gracell Biotechnologies annual CFO year-on-year change?
- What is the all time high quarterly CFO for Gracell Biotechnologies?
- What is the all time high TTM CFO for Gracell Biotechnologies?
What is Gracell Biotechnologies annual cash flow from operations?
The current annual CFO of GRCL is -$71.85 M
What is the all time high annual CFO for Gracell Biotechnologies?
Gracell Biotechnologies all-time high annual cash flow from operations is -$9.36 M
What is Gracell Biotechnologies annual CFO year-on-year change?
Over the past year, GRCL annual cash flow from operations has changed by -$24.69 M (-52.33%)
What is the all time high quarterly CFO for Gracell Biotechnologies?
Gracell Biotechnologies all-time high quarterly cash flow from operations is -$19.38 M
What is the all time high TTM CFO for Gracell Biotechnologies?
Gracell Biotechnologies all-time high TTM cash flow from operations is -$19.38 M